Tag: Cancer: Colon
Dual-Targeted Therapies Plus Chemo Improve Objective Response Rate in BRAF V600E Metastatic CRC
Significant and clinically relevant improvement seen in objective response rate with encorafenib + cetuximab plus mFOLFOX6
Blood Test May Provide New Option for Colorectal Cancer Screening
U.S. Census sex-age adjustments improved clinical performance estimates
Daily, Long-Term Aspirin Use Reduces Colorectal Cancer Recurrence
Findings seen for patients with somatic alterations in the PI3K signaling pathway
Early-Onset CRC Incidence Rates Increased in 27 of 50 Countries, Territories
Greatest increases in early-onset colorectal cancer incidence rates seen in New Zealand, Chile, Puerto Rico, and England
Accelerated Aging Linked to Increased Odds of Preneoplastic Polyps in the Colon
16 percent higher odds of harboring a PNP seen with one year of accelerated aging
Survival Up With Nivolumab + Ipilimumab Versus Chemo for Metastatic CRC
Findings seen in patients with microsatellite-instability-high or mismatch-repair-deficient metastatic colorectal cancer
Centralized CRC Screening Outreach Intervention Improves Screening Rates
Intervention participants were more likely to complete screening and to have detection of advanced colorectal neoplasia
Colorectal Cancer Risk Factors Important to Consider for Rescreening Interval
Findings seen for individuals with previous negative colonoscopy screening
Racial, Ethnic Disparities Seen in Mortality With Early-Onset Colorectal Cancer
Some of the differences explained by social determinants of health
ACG: GLP-1 RAs Tied to Lower Risk for Early-Onset Colorectal Cancer
Findings seen in people with type 2 diabetes
